Aminophylline loading in asthmatic patients: a protocol trial

Area of Science:

• Pharmacology
• Clinical Medicine
• Emergency Medicine

Background:

• Asthma exacerbations often require intravenous aminophylline for bronchodilation.
• Accurate aminophylline loading-dose calculation is crucial to achieve therapeutic levels while avoiding toxicity.

Purpose of the Study:

• To evaluate the efficacy and safety of an aminophylline loading-dose protocol in emergency department asthma patients.
• To compare the impact of total body weight (TBW) versus ideal body weight (IBW) dosing on aminophylline therapeutic levels.

Main Methods:

• Administered a half (3 mg/kg) or full (6 mg/kg) IV loading dose of aminophylline based on recent theophylline use.
• Dosing was calculated using total body weight (TBW).
• Compared achieved therapeutic and toxic theophylline levels between dosing groups.

Main Results:

• A full loading dose (6 mg/kg TBW) resulted in 71.4% achieving therapeutic levels with no toxicity.
• A half loading dose (3 mg/kg TBW) achieved therapeutic levels in 60.7% but led to toxicity in 23.2% of patients.
• Dosing based on ideal body weight (IBW) yielded similar results, suggesting neither TBW nor IBW is superior, especially in obese patients.

Conclusions:

• A full aminophylline loading dose (6 mg/kg TBW or 7.6 mg/kg IBW) is safe and effective for asthma patients with no recent theophylline use.
• Patients with recent theophylline use require preload blood level determination for safe and effective aminophylline dosing.
• Neither TBW nor IBW dosing is definitively superior, with variability noted in both, particularly in obese individuals.